164 related articles for article (PubMed ID: 27197304)
1. Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44.
Yi JM; Huan XJ; Song SS; Zhou H; Wang YQ; Miao ZH
Mol Cancer Ther; 2016 Jul; 15(7):1495-503. PubMed ID: 27197304
[TBL] [Abstract][Full Text] [Related]
2. Natural product triptolide mediates cancer cell death by triggering CDK7-dependent degradation of RNA polymerase II.
Manzo SG; Zhou ZL; Wang YQ; Marinello J; He JX; Li YC; Ding J; Capranico G; Miao ZH
Cancer Res; 2012 Oct; 72(20):5363-73. PubMed ID: 22926559
[TBL] [Abstract][Full Text] [Related]
3. XPB, a subunit of TFIIH, is a target of the natural product triptolide.
Titov DV; Gilman B; He QL; Bhat S; Low WK; Dang Y; Smeaton M; Demain AL; Miller PS; Kugel JF; Goodrich JA; Liu JO
Nat Chem Biol; 2011 Mar; 7(3):182-8. PubMed ID: 21278739
[TBL] [Abstract][Full Text] [Related]
4. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
5. Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).
Wang Y; Lu JJ; He L; Yu Q
PLoS One; 2011; 6(9):e23993. PubMed ID: 21931633
[TBL] [Abstract][Full Text] [Related]
6. Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA.
Vispé S; DeVries L; Créancier L; Besse J; Bréand S; Hobson DJ; Svejstrup JQ; Annereau JP; Cussac D; Dumontet C; Guilbaud N; Barret JM; Bailly C
Mol Cancer Ther; 2009 Oct; 8(10):2780-90. PubMed ID: 19808979
[TBL] [Abstract][Full Text] [Related]
7. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
[TBL] [Abstract][Full Text] [Related]
8. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
[TBL] [Abstract][Full Text] [Related]
9. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression.
Guo Q; Nan XX; Yang JR; Yi L; Liang BL; Wei YB; Zhu N; Hu SB; Zhang H; Luo Y; Xu YF
Neoplasma; 2013; 60(6):598-604. PubMed ID: 23906293
[TBL] [Abstract][Full Text] [Related]
11. Triptolide blocks the STAT3 signaling pathway through induction of protein tyrosine phosphatase SHP-1 in multiple myeloma cells.
Kim JH; Park B
Int J Mol Med; 2017 Nov; 40(5):1566-1572. PubMed ID: 28901387
[TBL] [Abstract][Full Text] [Related]
12. The genetic depletion or the triptolide inhibition of TFIIH in p53-deficient cells induces a JNK-dependent cell death in Drosophila.
Villicaña C; Cruz G; Zurita M
J Cell Sci; 2013 Jun; 126(Pt 11):2502-15. PubMed ID: 23549790
[TBL] [Abstract][Full Text] [Related]
13. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
14. Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells.
Zhao F; Chen Y; Zeng LL; Li R; Zeng R; Wen L; Liu Y; Zhang C
Acta Pharmacol Sin; 2010 Jun; 31(6):733-40. PubMed ID: 20523343
[TBL] [Abstract][Full Text] [Related]
15. Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1.
Nakazato T; Sagawa M; Kizaki M
Int J Oncol; 2014 Apr; 44(4):1131-8. PubMed ID: 24481531
[TBL] [Abstract][Full Text] [Related]
16. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
[TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits proliferation and invasion of malignant glioma cells.
Zhang H; Zhu W; Su X; Wu S; Lin Y; Li J; Wang Y; Chen J; Zhou Y; Qiu P; Yan G; Zhao S; Hu J; Zhang J
J Neurooncol; 2012 Aug; 109(1):53-62. PubMed ID: 22562416
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97.
Chauhan AK; Li P; Sun Y; Wani G; Zhu Q; Wani AA
Cell Cycle; 2021 Jan; 20(1):81-95. PubMed ID: 33381997
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
20. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
